logo
episode-header-image
Aug 2024
39m 37s

The Effect of Histone Demethylases on Ge...

Active Motif
About this episode
In this episode of the Epigenetics Podcast, we talked with Johnathan Whetstine from Fox Chase Cancer Center about his work on how histone demethylases affect gene expression and cancer cell stability. The Interview start by discussing a pivotal paper from Jonathan's lab in 2010, where they identified a role for the KDM4A histone demethylase in replication ti ... Show More
Up next
Jul 16
Antibodies, Automation, and the Fight for Reproducibility (Alon Goren)
In this episode we speak with Alon Goren from UC San Diego about his work at the intersection of genomic technology development and chromatin biology. We discuss how his lab studies how the epigenome is regulated, how disruption of that regulation contributes to disease, and how ... Show More
52m 39s
Jul 2
Long-Term Maintenance of Neuronal Identity (Tomohisa Toda)
In this episode of the Epigenetics Podcast, we talked with Tomohisa Toda from the Max-Planck-Zentrum für Physik und Medizin about his work on the long-term maintenance of neuronal identity, with a focus on epigenetic and RNA-based mechanisms in brain stability and aging. Dr. Toda ... Show More
38m 39s
Jun 18
Enhancer RNAs: Discovery and Function (Tae-Kyung Kim)
In this episode of the Epigenetics Podcast, we talked with Tae-Kyung Kim from POSTECH in South Korea about the discovery and characterisation of enhancer RNAs. Dr. Kim describes joining Danny Reinberg’s lab as a graduate student, where he was trained in protein biochemistry and g ... Show More
43m 14s
Recommended Episodes
Jul 2021
Engineering an Epigenome Editor
<p>On today’s episode we are discussing the results and implications of a recent study that describes the creation of a new set of tools to turn off or on any region in the genome with high specificity. Host Lauren Richardson and a16z general partner Vijay Pande are joined by the ... Show More
31m 38s
Oct 2015
Targeting epigenetics to treat cancer
Transcription is a tightly regulated process, where chemical modifications initiate the duplication of genetic material. This epigenetic process is often dysregulated in cancer, but it can be targeted with small molecule inhibitors. EPIGENETIC SIGNALLING Professor Panagis Filippa ... Show More
4m 37s
Sep 2025
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Feb 2023
ImmunoEpigenetics XXIX. Apoptosis unthwarted:preventing phosphorylation of RNAPOLII tanks histone acetylation near Mcl enhancer region thus epigenetically inhibiting expression in glioblastoma cells.
<p><strong>References</strong></p> <p>Cell Death &amp; Differentiation 2020.27: 3374–3385&nbsp;</p> <p>Cell Death &amp; Differentiation 2019. 26: 1501–1515</p> <p><em>Cancers</em> &nbsp;2020, <em>12</em>(8), 2137.</p> <p><br></p> <p><br></p> <p><br></p> 
29m 52s
Oct 2025
179. Back to Basics - Metastatic NSCLC feat. EGFR and ALK Driver Mutations
In this episode, Michael and Josh take a dive into the world of driver mutations, looking at two of the most clinically consequential: EGFR and ALK mutations. The work done in these areas has led to treatments that represent incredible advances over chemotherapy. How incredible? ... Show More
24m 44s
Apr 2023
Papers Unplugged: Precision Medicine and Myeloid Neoplasms
In this podcast, Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, discusses with Dr. Nathalie van Havre the role of genomic characterization in the classification, prognosis and treatment of myeloid neoplasms. Discover the main methods of genomic test ... Show More
14m 32s
Mar 2023
Papers Unplugged: Precision Medicine in AML
In this podcast, hear from Prof Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, as he discusses the growing roles of precise treatments based on the characteristics of the leukemic cells in acute myeloid leukemias. Discover the clinical developments ... Show More
11m 8s
Apr 2024
Rethinking Cancer: Inflammation, Infections, and Mitochondrial Insights with Mark Lintern : 1155
<p>Today's episode focuses on Cancer with a true expert, Mark Lintern. You'll learn about the surprising links between infections, inflammation, and our body's powerhouses - the mitochondria. This is a chance to arm yourself with cutting-edge theories that could change the way we ... Show More
1h 7m
Jun 2023
Unleashing CRISPR on Cancer
In this episode of “Intention to Treat,” host Rachel Gotbaum explores the story of a teenager who’s now in remission from previously relapsed lymphoblastic leukemia and talks with the investigator who developed the “off-the-shelf” CAR T cells that made her treatment possible. A f ... Show More
52m 50s